• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION ARTZ DISPO; ACID HYALURONIC INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION ARTZ DISPO; ACID HYALURONIC INTRAARTICULAR Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Bacterial Infection (1735)
Event Type  Injury  
Event Description
Unk - a female patient received an injection of artz dispo for periarthritis scapulohumeralis since 2019 or earlier.After 2 weeks, she had severe pain and visited a clinic.She was introduced and visited a university hospital.She was diagnosed with septic arthritis.Group b streptococcus was found in synovial fluid.
 
Manufacturer Narrative
This is a definitive report.The information was provided from japanese distributor.They received it on 2024-04-03.The reporter refused to cooperate investigations completely because the event had more than 5 years ago.According to the physician, it was considered that in the case of a common infection, inflammation would develop in a few days after the injection, but in this case, the infection developed 2 weeks later.The physician interviewed the patient, but there was no information on events that may have caused the infection.It was therefore the causal relationship between the event and artz dispo was unclear.The cause other than artz dispo was diabetes as concurrent disease.Company comment: all of product batches passed with the release test including the sterility test before the product release.It is therefore highly unlikely that the product quality was related to septic arthritis.Manufacturer's causality assessment is determined as "not related".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTZ DISPO
Type of Device
ACID HYALURONIC INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
6-1, marunouchi 1-chome
marunouchi center building
chiyoda-ku, tokyo 100 0 005
JA  100 0005
Manufacturer (Section G)
SEIKAGAKU CORPORATION - TAKAHAGI PLANT
258-5, aza-matsukubo
oaza-akahama
takahagi-shi, ibaraki 318 0 001
JA   318 0001
Manufacturer Contact
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100 0-005
MDR Report Key19160491
MDR Text Key340801445
Report Number9612392-2024-00005
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/03/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-